Author:
Chancellor Michael B.,Lucioni Alvaro,Staskin David
Funder
Sumitomo Pharma America Inc
Reference45 articles.
1. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline;Gormley;Am Urol Assoc,2019
2. Janssen Pharmaceuticals: Ditropan XL: oxybutynin chloride extended release tablets. Titusville, NJ; 2016.
3. Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults;Rai;Cochrane Database Syst Rev,2012
4. Overactive bladder in the elderly: a guide to pharmacological management;Staskin;Drugs Aging,2005
5. Association between cumulative anticholinergic burden and falls and fractures in patients with overactive bladder: US-based retrospective cohort study;Szabo;BMJ Open,2019